Mutational analysis of the primary substrate specificity pocket of complement factor B -: Asp226 is a major structural determinant for P1-Arg binding

被引:15
作者
Xu, YY
Circolo, A
Jing, H
Wang, Y
Narayana, SVL
Volanakis, JE
机构
[1] Univ Alabama, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
[2] Univ Alabama, Ctr Macromol Crystallog, Birmingham, AL 35294 USA
[3] Harvard Univ, Sch Med, Ctr Blood Res, Cambridge, MA 02138 USA
[4] Biomed Sci Res Ctr A Fleming, Vari 16672, Greece
关键词
D O I
10.1074/jbc.275.1.378
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factor B is a serine protease, which despite its trypsin-like specificity has Asn instead of the typical Asp at the bottom of the S-1 pocket (position 189, chymotrypsinogen numbering). Asp residues are present at positions 187 and 226 and either one could conceivably provide the negative charge for binding the P-1-Arg of the substrate. Determination of the crystal structure of the factor B serine protease domain has revealed that the side chain of Asp(226) is within the S-1 pocket, whereas Asp(187) is located outside the pocket. To investigate the possible role of these atypical structural features in substrate binding and catalysis, we constructed a panel of mutants of these residues. Replacement of Asp(187) caused moderate (50-60%) decrease in hemolytic activity, compared with wild type factor B, whereas replacement of Asn(189) resulted in more profound reductions (71-95%). Substitutions at these two positions did not significantly affect assembly of the alternative pathway C3 convertase. In contrast, elimination of the negative charge from Asp(296) completely abrogated hemolytic activity and also affected formation of the C3 convertase. Kinetic analyses of the hydrolysis of a P-1-Arg containing thioester by selected mutants confirmed that residue Asp(226) is a primary structural determinant for P-1-Arg binding and catalysis.
引用
收藏
页码:378 / 385
页数:8
相关论文
共 40 条
[1]  
AGRAWAL A, 1992, J BIOL CHEM, V267, P25353
[2]   The atypical serine proteases of the complement system [J].
Arlaud, GJ ;
Volanakis, JE ;
Thielens, NM ;
Narayana, SVL ;
Rossi, V ;
Xu, YY .
ADVANCES IN IMMUNOLOGY, VOL 69, 1998, 69 :249-307
[3]  
CAPORALE LH, 1981, J IMMUNOL, V126, P1963
[4]  
CIRCOLO A, 1997, COMPLEMENT PRACTICAL, P199
[5]   REFINED CRYSTAL-STRUCTURE OF GAMMA-CHYMOTRYPSIN AT 1.9 A RESOLUTION - COMPARISON WITH OTHER PANCREATIC SERINE PROTEASES [J].
COHEN, GH ;
SILVERTON, EW ;
DAVIES, DR .
JOURNAL OF MOLECULAR BIOLOGY, 1981, 148 (04) :449-479
[6]   ENZYMATIC-ACTIVITY OF 2ND COMPONENT OF COMPLEMENT [J].
COOPER, NR .
BIOCHEMISTRY, 1975, 14 (19) :4245-4251
[7]   REDESIGNING TRYPSIN - ALTERATION OF SUBSTRATE-SPECIFICITY [J].
CRAIK, CS ;
LARGMAN, C ;
FLETCHER, T ;
ROCZNIAK, S ;
BARR, PJ ;
FLETTERICK, R ;
RUTTER, WJ .
SCIENCE, 1985, 228 (4697) :291-297
[8]   Structural and energetic determinants of the S1-site specificity in serine proteases [J].
Czapinska, H ;
Otlewski, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 260 (03) :571-595
[9]   SUBSTRATE-SPECIFICITY OF TRYPSIN INVESTIGATED BY USING A GENETIC SELECTION [J].
EVNIN, LB ;
VASQUEZ, JR ;
CRAIK, CS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6659-6663
[10]   The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies [J].
Fujinaga, M ;
Chernaia, MM ;
Halenbeck, R ;
Koths, K ;
James, MNG .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 261 (02) :267-278